Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clin...
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis....
Zemaira Eosinophilic Esophagitis Pilot Study
This is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis....
Top Cities for Eosinophilic Esophagitis Clinical Trials
Eosinophilic Esophagitis clinical trials are recruiting across 22 cities. Here are the cities with the most active studies:
About Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is a chronic allergic/immune condition where eosinophils accumulate in the esophagus, causing inflammation and difficulty swallowing. Prevalence has been increasing in recent decades. Treatment includes dietary elimination, proton pump inhibitors, and topical corticosteroids.
Clinical trials are advancing new treatments for eosinophilic esophagitis. Currently, 3 studies are recruiting a combined 480 participants across the United States. Research is being conducted by 3 organizations including Dr. Falk Pharma GmbH, Uniquity One (UNI), Children's Hospital Medical Center, Cincinnati.
2026 Eosinophilic Esophagitis Research Landscape
As of March 2026, the eosinophilic esophagitis clinical trial landscape includes 3 actively recruiting studies across 22 cities in the United States. These studies are collectively seeking 480 participants, with an average enrollment target of 160 per study.
Research is being led by 3 different organizations, including Dr. Falk Pharma GmbH, Uniquity One (UNI), Children's Hospital Medical Center, Cincinnati.
Geographically, eosinophilic esophagitis trials are most concentrated in La Jolla, California (1 trial); Lomita, California (1 trial); Houma, Louisiana (1 trial); Marrero, Louisiana (1 trial); Boston, Massachusetts (1 trial) and 7 other cities.
Featured Eosinophilic Esophagitis Studies
Highlighted recruiting studies for eosinophilic esophagitis, selected by enrollment size and research scope.
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
The purpose of this study is to prove the non-inferiority of a 6-weeks treatment with 1 mg budesonide orodispersible tablets BID versus 2 mg budesonide orodispesible tabletss for the induction of clinico-pathological remission in adult patients with active eosinophilic esophagitis.
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis.
Zemaira Eosinophilic Esophagitis Pilot Study
This is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis.
Frequently Asked Questions About Eosinophilic Esophagitis Clinical Trials
Are there eosinophilic esophagitis clinical trials near me?
Yes, there are 3 eosinophilic esophagitis clinical trials currently recruiting across 22+ cities in the United States, including La Jolla, California; Lomita, California; Houma, Louisiana. Browse the studies above to find one at a location convenient for you.
How do I join a eosinophilic esophagitis clinical trial?
To join a eosinophilic esophagitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are eosinophilic esophagitis clinical trials free?
Yes, participation in eosinophilic esophagitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of eosinophilic esophagitis treatments are being studied?
Current eosinophilic esophagitis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 3 research organizations.
Is it safe to participate in eosinophilic esophagitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov